Lykos Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
64
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$50M
- Investors
-
26
Lykos Therapeutics General Information
Description
Provider of psychedelic medicines and therapies intended to help people heal and grow. The company specializes in the research, development, and integration of psychedelic medicines and therapies into the healthcare system, applying evidence-based research to create investigational psychedelics to catalyze therapeutic approaches for mental health conditions, enabling adults with post-traumatic stress disorder to address unmet needs in the mental healthcare space.
Contact Information
Website
www.lykospbc.comCorporate Office
- 3141 Stevens Creek Boulevard
- Suite 40547
- San Jose, CA 95117
- United States
Corporate Office
- 3141 Stevens Creek Boulevard
- Suite 40547
- San Jose, CA 95117
- United States
Lykos Therapeutics Timeline
Lykos Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 25-Aug-2025 | $50M | Completed | Clinical Trials - Phase 4 | ||
| 2. Later Stage VC (Series A) | 05-Jan-2024 | Completed | Clinical Trials - Phase 4 | |||
| 1. Later Stage VC | 01-Jan-2022 | Completed | Clinical Trials - Phase 4 |
Lykos Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lykos Therapeutics Comparisons
Industry
Financing
Details
Lykos Therapeutics Competitors (2)
One of Lykos Therapeutics’s 2 competitors is Definium Therapeutics, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Definium Therapeutics | Formerly VC-backed | New York, NY | ||||
| Vistagen Therapeutics | Corporation | South San Francisco, CA |
Lykos Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lykos Therapeutics Patents
Lykos Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4611738-A1 | Compositions comprising mdma and methods of using same | Pending | 05-Dec-2022 | ||
| US-20240285577-A1 | Compositions comprising mdma and methods of using same | Pending | 05-Dec-2022 | ||
| US-20250127756-A1 | Compositions comprising mdma and methods of using same | Inactive | 05-Dec-2022 | ||
| US-20250127757-A1 | Compositions comprising mdma and methods of using same | Inactive | 05-Dec-2022 | ||
| US-20250134855-A1 | Compositions comprising mdma and methods of using same | Pending | 05-Dec-2022 | A61K31/36 |
Lykos Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lykos Therapeutics Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AIC Holdings | Family Office | Minority | ||
| Ch Foundation | Corporation | Minority | ||
| Gracias Family Found ation | Corporation | Minority | ||
| Momentis (Omaha) | Family Office | Minority | ||
| Air Therapeutics | Corporation | Minority |
Lykos Therapeutics FAQs
-
When was Lykos Therapeutics founded?
Lykos Therapeutics was founded in 2014.
-
Where is Lykos Therapeutics headquartered?
Lykos Therapeutics is headquartered in San Jose, CA.
-
What is the size of Lykos Therapeutics?
Lykos Therapeutics has 64 total employees.
-
What industry is Lykos Therapeutics in?
Lykos Therapeutics’s primary industry is Drug Discovery.
-
Is Lykos Therapeutics a private or public company?
Lykos Therapeutics is a Private company.
-
What is Lykos Therapeutics’s current revenue?
The current revenue for Lykos Therapeutics is .
-
How much funding has Lykos Therapeutics raised over time?
Lykos Therapeutics has raised $150M.
-
Who are Lykos Therapeutics’s investors?
AIC Holdings, Ch Foundation, Gracias Family Found ation, Momentis (Omaha), and Air Therapeutics are 5 of 26 investors who have invested in Lykos Therapeutics.
-
Who are Lykos Therapeutics’s competitors?
Definium Therapeutics and Vistagen Therapeutics are competitors of Lykos Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
